Suchergebnisse - "Chesov, Dumitru"

PubPharm (39)

1

Drug-Resistant Tuberculosis, Georgia, Kazakhstan, Kyrgyzstan, Moldova, and Ukraine, 2017-2022

enthalten in: Emerging infectious diseases | 2024

von Dahl, V. | Butova, T. | Rosenthal, A. | +13

2

Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2024

von Günther, G. | Guglielmetti, L. | Kherabi, Y. | +54

3

Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis: a mathematical modeling analysis

enthalten in: bioRxiv.org | 2024

von James, L. | Klaassen, F. | Sweeney, S. | +9

4

Impact of Mycobacterium tuberculosis strain type on multidrug-resistant tuberculosis severity, Republic of Moldova

enthalten in: The Journal of infection | 2023

von Chesov, E. | Chesov, D. | Reimann, M. | +8

5

Recent advances in the treatment of tuberculosis

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Motta, I. | Boeree, M. | Chesov, D. | +20

6

Long-term treatment outcomes in patients with multidrug-resistant tuberculosis

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Maier, C. | Chesov, D. | Schaub, D. | +5

7

Limited Nosocomial Transmission of Drug-Resistant Tuberculosis, Moldova

enthalten in: Emerging infectious diseases | 2023

von Noroc, E. | Chesov, D. | Merker, M. | +7

8

Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis : a 2023 TBnet/RESIST-TB consensus statement

enthalten in: The Lancet. Infectious diseases | 2023

von Domínguez, J. | Boeree, M. | Cambau, E. | +54

ErratumIn: Lancet Infect Dis. 2023 Mar 28;:. - PMID 37001542

9

A retrospective genomic analysis of drug-resistant strains of M. tuberculosis in a high-burden setting, with an emphasis on comparative diagnostics and reactivation and reinfection status.

enthalten in: ResearchSquare.com | 2022

von Wollenberg, K. | Harris, M. | Gabrielian, A. | +8

10

A retrospective genomic analysis of drug-resistant strains of M. tuberculosis in a high-burden setting, with an emphasis on comparative diagnostics and reactivation and reinfection status

enthalten in: ResearchSquare.com | 2022

von Wollenberg, K. | Harris, M. | Gabrielian, A. | +8